Adverts

Open Access Articles- Top Results for Anileridine

Anileridine

</th></tr></th></tr></th></tr>
Anileridine
150px
Systematic (IUPAC) name
Ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate
Clinical data
AHFS/Drugs.com monograph
Tablets, injection
Pharmacokinetic data
Protein binding > 95%
Metabolism Hepatic
Identifiers
144-14-9 7pxY
N01AH05
PubChem CID 8944
DrugBank DB00913 7pxY
ChemSpider 8600 7pxY
UNII 71Q1A3O279 7pxY
KEGG D02941 7pxY
ChEBI CHEBI:61203 7pxY
ChEMBL CHEMBL1201347 7pxN
Chemical data
Formula C22H28N2O2
352.47 g/mol
Physical data
Melting point Script error: No such module "convert".
 14pxN (what is this?)  (verify)

Anileridine (trade name: Leritine) is a synthetic analgesic drug and is a member of the piperidine class of analgesic agents developed by Merck & Co. in the 1950s.[1] It differs from pethidine (meperidine) in that the N-methyl group of meperidine is replaced by an N-aminophenethyl group, which increases its analgesic activity.

Anileridine is no longer manufactured in the US or Canada.[2]

Administration

As tablets or injection.[3]

Pharmacokinetics

Anileridine usually takes effect within 15 minutes of either oral or intravenous administration, and lasts 2–3 hours.[4] It is mostly metabolized by the liver.

References

  1. ^ U.S. Patent 2,897,204
  2. ^ "Discontinued Prescription Drug Products". Canadian Pharmacists' Association. Retrieved 28 July 2008. 
  3. ^ "Pharmaceutical Information - LERITINE". RxMed. Retrieved 16 June 2010. 
  4. ^ "Anileridine Consumer Information". MedicineNet. Retrieved 28 July 2008. 


Template:Opioidergics


Lua error in package.lua at line 80: module 'Module:Buffer' not found.